September 3, 2024
Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer
Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage…